Impact of comorbidity on outcome and treatment choice in patients with head and neck squamous cell carcinoma (HNSCC).

被引：0
|
作者：
Giacinti, Silvana
Giannarelli, Diana
Moi, Rossana
Battista, Michele
Perfetti, Alessandra
Ferrari, Laura
Alo, Piero Luigi
Costanzo, Filippo
Marzetti, Andrea
Cognetti, Francesco
Nistico, Cecilia
机构：
[1] ASL Frosinone, Med Oncol Unit, Frosinone, Italy
[2] IRCCS, Regina Elena Natl Canc Inst, Biostat Unit, Rome, Italy
[3] ASL FR, Otorinolaringoyathry Dept, Frosinone, Italy
[4] ASL FR, Dept Radiotherapy, Sora, Italy
[5] ASL FR, Dept Pathol, Frosinone, Italy
[6] ASL FR, Dept Med Oncol, Sora, Italy
[7] ASL FR, Dept Radiol, Frosinone, Italy
[8] UniCamillus Int Med Univ, Rome, Italy
[9] ASL FR, Dept Med Oncol, Frosinone, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18033
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [41] Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial
    Fernandez-Mateos, Javier
    Perez-Garcia, Jessica
    Seijas-Tamayo, Raquel
    Mesia, Ricard
    Rubio-Casadevall, Jordi
    Garcia-Giron, Carlos
    Iglesias, Lara
    Carral Maseda, Alberto
    Adansa Klain, Juan Carlos
    Taberna, Miren
    Vazquez, Silvia
    Asuncion Gomez, Maria
    del Barco, Edel
    Ocana, Alberto
    Gonzalez-Sarmiento, Rogelio
    Jesus Cruz-Hernandez, Juan
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [42] Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial
    Javier Fernández-Mateos
    Jéssica Pérez-García
    Raquel Seijas-Tamayo
    Ricard Mesía
    Jordi Rubió-Casadevall
    Carlos García-Girón
    Lara Iglesias
    Alberto Carral Maseda
    Juan Carlos Adansa Klain
    Miren Taberna
    Silvia Vazquez
    María Asunción Gómez
    Edel del Barco
    Alberto Ocana
    Rogelio González-Sarmiento
    Juan Jesús Cruz-Hernández
    Scientific Reports, 10
  • [43] Risk Factors for Prolonged Diagnosis to Treatment Interval (DTI) Among Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
    Sharma, S.
    Bekelman, J. E.
    Lin, A.
    Roman, B.
    Mitra, N.
    Swisher-McClure, S. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S558 - S558
  • [44] The association of treatment delay and prognosis in head and neck squamous cell carcinoma (HNSCC) patients in a Dutch comprehensive cancer center
    van Harten, Michel C.
    de Ridder, Mischa
    Hamming-Vrieze, Olga
    Smeele, Ludi E.
    Balm, Alfons J. M.
    van den Brekel, Michiel W. M.
    ORAL ONCOLOGY, 2014, 50 (04) : 282 - 290
  • [45] Effect of Comorbidity on Post-Treatment Quality of Life Scores in Patients With Head and Neck Squamous Cell Carcinoma
    Gourin, Christine G.
    Boyce, Brian J.
    Vaught, Creighton C.
    Burkhead, Lori M.
    Podolsky, Robert H.
    LARYNGOSCOPE, 2009, 119 (05): : 907 - 914
  • [46] Integrins in head and neck squamous cell carcinoma (HNSCC): A review of the current literature
    Georgolios, AK
    Batistatou, A
    Charalabopoulos, K
    CELL COMMUNICATION AND ADHESION, 2005, 12 (1-2): : 1 - 8
  • [47] Effects of Exosomes on B Cell Populations in Head and Neck Squamous Cell Carcinoma (HNSCC)
    Schroeder, Jan Christian
    Jeske, Sandra S.
    Hoffmann, Thomas K.
    Bruner, Cornelia
    Theodoraki, Marie-Nicole
    Schuler, Patrick J.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 97 - 97
  • [48] Sequential neoadjuvant chemotherapy (SC) for head and neck squamous cell carcinoma (HNSCC)
    Rixe, O
    Gatineau, M
    Batouche, M
    Raymond, E
    Domenge, C
    Janot, F
    Schwaab, G
    Luboinski, B
    Armand, JP
    ANNALS OF ONCOLOGY, 1998, 9 : 175 - 175
  • [49] A pilot study of raltegravir and cisplatin in head and neck squamous cell carcinoma (HNSCC).
    Bauman, Julie E.
    Olson, Garth T.
    Spafford, Michael
    Nuara, Michael
    Sampath, Sagus
    Lee, Sang-Joon
    Williamson, Elizabeth A.
    Wu, Yuehan
    Sklar, Larry A.
    Oprea, Tudor I.
    Hromas, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Chromosomal imbalances predict survival in head and neck squamous cell carcinoma (HNSCC)
    Bauer, Verena
    Braselmann, Herbert
    Zitzelsberger, Horst
    Unger, Kristian
    Henke, Michael
    Walch, Axel
    CELLULAR ONCOLOGY, 2008, 30 (03) : 248 - 249
12345